I know.I am in this stock in a big way since 1996. every DRP. Now with all the adulation for the MBL model, Merril Lynch says that MIG is just as good
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress